Mycoses

Article	Citations
COVID‐19 associated pulmonary aspergillosis	412
COVID‐19‐associated mucormycosis: An updated systematic review of literature	168
Invasive pulmonary aspergillosis in the COVID‐19 era: An expected new entity	136
COVID‐19‐associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID‐19 pneumonia: An observational study from Pakistan	125
ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐ and middle‐income countries	125
The double‐edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza‐associated mucormycosis versus COVID‐19 associated mucormycosis	125
Alarming India‐wide phenomenon of antifungal resistance in dermatophytes: A multicentre study	120
Increased incidence of candidemia in a tertiary care hospital with the COVID‐19 pandemic	111
Mucormycosis and COVID‐19: An epidemic within a pandemic in India	108
Oropharyngeal candidiasis in hospitalised COVID‐19 patients from Iran: Species identification and antifungal susceptibility pattern	97
Breakthrough invasive fungal infections: Who is at risk?	94
Mucormycosis in patients with COVID‐19: A cross‐sectional descriptive multicentre study from Iran	94
Incidence and mortality of COVID‐19‐associated pulmonary aspergillosis: A systematic review and meta‐analysis	73
Characteristics of candidemia in COVID‐19 patients; increased incidence, earlier occurrence and higher mortality rates compared to non‐COVID‐19 patients	60
Prevalence of opportunistic invasive aspergillosis in COVID‐19 patients with severe pneumonia	59
Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k)	55
Epidemiology and Mycology of Candidaemia in non‐oncological medical intensive care unit patients in a tertiary center in the United States: Overall analysis and comparison between non‐COVID‐19 and COV	49
COVID‐19–associated pulmonary aspergillosis: a prospective single‐center dual case series	45
Invasive aspergillosis in critically ill patients: Review of definitions and diagnostic approaches	45
Isolation of Aspergillus spp. in respiratory samples of patients with COVID‐19 in a Spanish Tertiary Care Hospital	45
Clinical characteristics and outcomes of invasive Lomentospora prolificans infections: Analysis of patients in the FungiScope® registry	41
Treatment of invasive fungal diseases in cancer patients—Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)	40
Accuracy of galactomannan testing on tracheal aspirates in COVID‐19‐associated pulmonary aspergillosis	39
Invasive dermatophyte infection: A systematic review	38
Results from a national survey on COVID‐19‐associated mucormycosis in Germany: 13 patients from six tertiary hospitals	37

Axillary Digital Thermometers uplifted a multidrug‐susceptible Candidaauris outbreak among COVID‐19 patients in Brazil	37
Fluconazole‐resistant Candida parapsilosis strains with a Y132F substitution in the ERG11 gene causing invasive infections in a neonatal unit, South Africa	35
Increased incidence of rhino‐orbital mucormycosis in an educational therapeutic hospital during the COVID‐19 pandemic in western Iran: An observational study	33
Is there an association between zinc and COVID‐19–associated mucormycosis? Results of an experimental and clinical study	32
Global prevalence and subgroup analyses of coronavirus disease (COVID‐19) associated Candida auris infections (CACa): A systematic review and meta‐analysis	32
Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: Fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure	32
Mucormycosis in the Middle East and North Africa: Analysis of the FungiScope® registry and cases from the literature	31
Putative invasive pulmonary aspergillosis in critically ill patients with COVID‐19: An observational study from New York City	30
Proven COVID‐19—associated pulmonary aspergillosis in patients with severe respiratory failure	29
Gut mycobiome: The probable determinative role of fungi in IBD patients	29
Impact of tolerance to fluconazole on treatment response in Candida albicans bloodstream infection	29
Epidemiology of invasive fungal disease in haematologic patients	28
Serum iron indices in COVID‐19‐associated mucormycosis: A case–control study	26
Molecular characterisation of Candida auris isolates from immunocompromised patients in a tertiary‐care hospital in Kuwait reveals a novel mutation in FKS1 conferring reduced susceptibil	26
Adult tinea capitis in China: A retrospective analysis from 2000 to 2019	25
Systematic screening for COVID‐19 associated invasive aspergillosis in ICU patients by culture and PCR on tracheal aspirate	25
Estimation of the burden of tinea capitis among children in Africa	25
Let's talk about sex characteristics—As a risk factor for invasive fungal diseases	25
Sarocladium and Acremonium infections: New faces of an old opportunistic fungus	25
Mortality in critically ill patients with coronavirus disease 2019‐associated pulmonary aspergillosis: A systematic review and meta‐analysis	25
Talaromyces marneffei infection in non–HIV‐infected patients in mainland China	24
Prevalence, risk factors, treatment and outcome of multidrug resistance Candida auris infections in Coronavirus disease (COVID‐19) patients: A systematic review	24
Effects of antifungal stewardship using therapeutic drug monitoring in voriconazole therapy on the prevention and control of hepatotoxicity and visual symptoms: A multicentre study conducted in Japan	24
Risk factors for candidaemia: A prospective multi‐centre case‐control study	23
Attributable mortality of candidemia after introduction of echinocandins	23
Trichosporon asahii superinfections in critically ill COVID‐19 patients overexposed to antimicrobials and corticosteroids	23
COVID‐19‐associated pulmonary aspergillosis (CAPA): Risk factors and development of a predictive score for critically ill COVID‐19 patients	22
Indian Trichophyton mentagrophytes squalene epoxidase erg1 double mutants show high proportion of combined fluconazole and terbinafine resistance	22
Evaluation of DermaGenius® resistance real‐time polymerase chain reaction for rapid detection of terbinafine‐resistant Trichophyton species	22
Species distribution, azole resistance and related molecular mechanisms in invasive Candida parapsilosis complex isolates: Increase in fluconazole resistance in 21 years	22
Epidemiology, clinical features, diagnosis and treatment of cerebral mucormycosis in diabetic patients: A systematic review of case reports and case series	22
Incidence, risk factors and mortality of invasive pulmonary aspergillosis in patients with influenza: A systematic review and meta‐analysis	21
Bronchoscopy safety precautions for diagnosing COVID‐19 associated pulmonary aspergillosis—A simulation study	21
Burden of serious fungal infections in the Netherlands	21
The influence of CYP2C19 polymorphisms on voriconazole trough concentrations: Systematic review and meta‐analysis	21
Isavuconazole therapeutic drug monitoring in critically ill ICU patients: A monocentric retrospective analysis	20
South Asian (Clade I) Candida auris meningitis in a paediatric patient in Iran with a review of the literature	20
Host immune responses in dermatophytes infection	20
Kodamaea ohmeri infections in humans: A systematic review	20
Point mutations in the squalene epoxidase erg1 and sterol 14‐α demethylase erg11 gene of T indotineae isolates indicate that the resistant mutant strains evolved independently	19
Tinea capitis et barbae caused by Trichophyton tonsurans: A retrospective cohort study of an infection chain after shavings in barber shops	19
A review of significance of Aspergillus detection in airways of ICU COVID‐19 patients	19
In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes	18
Collateral consequences of agricultural fungicides on pathogenic yeasts: A One Health perspective to tackle azole resistance	18
Glucan rich nutrition does not increase gut translocation of beta‐glucan	17
Evaluation of the new Id‐Fungi plates from Conidia for MALDI‐TOF MS identification of filamentous fungi and comparison with conventional methods as identification tool for dermatophytes from nails, ha	17
Superficial mycoses, a matter of concern: Global and Indian scenario‐an updated analysis	17
Predicting a therapeutic cut‐off serum level of itraconazole in recalcitrant tinea corporis and cruris—A prospective trial	17
Disseminated cryptococcosis and anti‐granulocyte‐macrophage colony‐stimulating factor autoantibodies: An underappreciated association	16
Proven Aspergillus flavus pulmonary aspergillosis in a COVID‐19 patient: A case report and review of the literature	16

Expert recommendations for prevention and management of Candida auris transmission	16
Role of recombinant Aspergillus fumigatus antigens in diagnosing Aspergillus sensitisation among asthmatics	16
Azole resistance in Aspergillus fumigatus. The first 2‐year's Data from the Danish National Surveillance Study, 2018–2020	15
Successful control of Candida auris transmission in a German COVID‐19 intensive care unit	15
Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA)	15
COVID‐19–associated mucormycosis, diabetes and steroid therapy: Experience in a single centre in Western Mexico	15
Superficial fungal infections in the department of dermatology, University Hospital Jena: A 7‐year retrospective study on 4556 samples from 2007 to 2013	15
Molecular identification and antifungal susceptibility among clinical isolates of dermatophytes in Shiraz, Iran (2017‐2019)	15
Complementary effect of mechanism of multidrug resistance in Trichophyton mentagrophytes isolated from human dermatophytoses of animal origin	15
Mucormycosis at a tertiary‐care center in Mexico. A 35‐year retrospective study of 214 cases	15
Landmark clinical observations and immunopathogenesis pathways linked to HIV and Cryptococcus fatal central nervous system co‐infection	15
In vitro antidermatophytic synergism of double and triple combination of clioquinol with ciclopirox and terbinafine	14
Malignant Transformation and Treatment Recommendations of Chronic Hyperplastic Candidiasis—A Six‐year Retrospective Cohort Study	14
Inflammasome‐mediated Inflammation by Malassezia in human keratinocytes: A comparative analysis with different strains	14
Non‐Aspergillus invasive mould infections in patients treated with ibrutinib	14
New weapons to fight a new enemy: A systematic review of drug combinations against the drug‐resistant fungus Candida auris	14
Performance evaluation of fungal DNA PCR amplification from formalin‐fixed paraffin‐embedded tissue for diagnosis: Experience of a tertiary reference laboratory	14
Tinea pedis—An embarrassing problem for health and beauty—A narrative review	14
Anti‐fungal agents in the treatment of chronic pulmonary aspergillosis: Systematic review and a network meta‐analysis	14
Clinical features, diagnosis and treatment outcome of fungal endocarditis: A systematic review of reported cases	13
A screening study for COVID‐19‐associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic	13
Therapeutic drug monitoring of posaconazole delayed release tablet while managing COVID‐19–associated mucormycosis in a real‐life setting	13
Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two‐centre mixed cohort study	13
Comparison of four commercially available chromogenic media to identify Candida albicans and other medically relevant Candida species	13
Invasive aspergillosis due to Aspergillus cryptic species: A prospective multicentre study	13
Fungal endocarditis in transplant recipients: A systematic review	13
Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south‐eastern Brazil	13
Characteristics, outcome and risk factors for mortality of paediatric patients with ICU‐acquired candidemia in India: A multicentre prospective study	13
Risk factors for mortality in patients with pulmonary mucormycosis	13
Cryptococcosis among hospitalised patients with COVID‐19: A multicentre research network study	12
Alternative treatment of fungal infections: Synergy with non‐antifungal agents	12
Yarrowia lipolytica causes sporadic cases and local outbreaks of infections and colonisation	12
Isothermal nucleic acid amplification techniques for detection and identification of pathogenic fungi: A review	12
Role of arthroconidia in biofilm formation by Trichosporon asahii	12
Quantification of 1,3‐β‐d‐glucan by Wako β‐glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study	12
Frequency of occurrence, seasonal variation and antifungal susceptibility of opportunistic Mucorales isolated from hospital soils in Iran	12
Molecular identification and antifungal susceptibility profiles of Candida dubliniensis and Candida africana isolated from vulvovaginal candidiasis: A single‐centre experience in Iran	12
Epidemiology and outcomes of allergic bronchopulmonary aspergillosis in the elderly	11
Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis	11
Molecular‐based assessment of diversity and population structure of Sporothrix spp. clinical isolates from Espírito Santo‐Brazil	11
Chronic pulmonary aspergillosis in patients with active pulmonary tuberculosis with persisting symptoms in Uganda	11
A multicentric clinical and epidemiological study of chronic and recurrent dermatophytosis in India	11
Antifungal susceptibility testing of dermatophytes: Development and evaluation of an optimised broth microdilution method	11
Laboratory‐based surveillance of Candida auris in Colombia, 2016–2020	11
Multimodal analysis of the COVID‐19‐associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors	11
Dysbiosis of skin mycobiome in atopic dermatitis	11
The design and application of an automated microscope developed based on deep learning for fungal detection in dermatology	11
Sensitization to A fumigatus in subjects with non‐cystic fibrosis bronchiectasis	11
Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study)	11
Validation and implementation of a commercial real‐time PCR assay for direct detection of Candida auris from surveillance samples	11
Deep learning‐based diagnosis models for onychomycosis in dermoscopy	11
Diabetic versus non‐diabetic rhino‐orbito‐cerebral mucormycosis	11
Epidemiology, clinical presentation and management of COVID‐19 associated mucormycosis: A single centre experience from Pune, Western India	11
Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID‐19‐associated pulmonary aspergillosis	11
How does temperature trigger biofilm adhesion and growth in Candida albicans and two non‐Candida albicans Candida species?	11
Outcome and characteristics of invasive fungal infections in critically ill burn patients: A multicenter retrospective study	11
Global epidemiological burden of fungal infections in cirrhosis patients: A systematic review with meta‐analysis	10
Identification of Candida auris and related species by multiplex PCR based on unique GPI protein‐encoding genes	10
Incidence and risk factors for COVID‐19 associated candidemia (CAC) in ICU patients	10
Implementation of rapid diagnostics assays for detection of histoplasmosis and cryptococcosis in central american people living with HIV	10
Role of flexible bronchoscopy in the diagnosis of invasive fungal infections	10
Invasive Scedosporium and Lomentosora infections in the era of antifungal prophylaxis: A 20‐year experience from a single centre in Spain	10
Non‐dermatophyte fungi in onychomycosis—Epidemiology and consequences for clinical practice	10
A pseudo‐outbreak of Rhinocladiella similis in a bronchoscopy unit of a tertiary care teaching hospital in London, United Kingdom	10
Serum Aspergillus galactomannan lateral flow assay for the diagnosis of invasive aspergillosis: A single‐centre study	10
Aspergillus‐PCR in bronchoalveolar lavage ‐ diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients	10
Drug repurposing against Candida auris: A systematic review	10
Different susceptibility of spores and hyphae of Trichophyton rubrum to methylene blue mediated photodynamic treatment in vitro	10
Rare/cryptic Aspergillus species infections and importance of antifungal susceptibility testing	10
Effect of CYP2C19 polymorphism on the plasma voriconazole concentration and voriconazole‐to‐voriconazole‐N‐oxide concentration ratio in elderly patients	10
Increasing morbidity and mortality of candidemia over one decade in a Swiss university hospital	10
Diagnostic performance of real‐time polymerase chain reaction assay on blood for invasive aspergillosis and mucormycosis	10
Serious fungal disease incidence and prevalence in Indonesia	10
Genetic differences between Japan and other countries in cyp51A polymorphisms of Aspergillus fumigatus	10
Comparative effectiveness of amphotericin B, azoles and echinocandins in the treatment of candidemia and invasive candidiasis: A systematic review and network meta‐analysis	9
COVID‐19‐associated pulmonary aspergillosis in ICU patients in a German reference centre: Phenotypic and molecular characterisation of Aspergillus fumigatus isolates	9
Azole resistance in Aspergillus isolates by different types of patients and correlation with environment ‐ An Italian prospective multicentre study (ARiA study)	9
The best type of inoculum for testing the antifungal drug susceptibility of Microsporum canis: In vivo and in vitro results	9
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole	9
Epidemiology of Cryptococcus and cryptococcosis in Western Africa	9

5‐Aminolevulinic acid‐mediated photodynamic therapy has effective antifungal activity against Sporothrix globosa in vitro	9
How can we optimise antifungal use in a solid organ transplant centre? Local epidemiology and antifungal stewardship implementation: A single‐centre study	9
Five‐year surveillance study of clinical and environmental Triazole‐ResistantAspergillus fumigatus isolates in Iran	9
High prevalence of triazole‐resistant Aspergillus fumigatus sensu stricto in an Argentinean cohort of patients with cystic fibrosis	9
Invasive fungal infections in acute and chronic liver impairment: A systematic review	9
Persistent vs non‐persistent candidaemia in adult patients in 2007‐2016: A retrospective cohort study	9
Evaluation of two lateral flow assays in BAL fluids for the detection of invasive pulmonary aspergillosis: A retrospective two‐centre study	9
Candidaemia in the elderly: Epidemiology, management and adherence to the European Confederation of Medical Mycology quality indicators	9
The cost‐effectiveness of isavuconazole compared to voriconazole, the standard of care in the treatment of patients with invasive mould diseases, prior to differential pathogen diagnosis in Spain	9
Antidermatophytic activity of synthetic peptides: Action mechanisms and clinical application as adjuvants to enhance the activity and decrease the toxicity of Griseofulvin	9
Tinea capitis in children: A single‐institution retrospective review from 2011 to 2019	9
Epidemiology of dermatomycoses and onychomycoses in Ireland (2001–2020): A single‐institution review	9
COVID‐19‐associated subacute invasive pulmonary aspergillosis	9
Itraconazole resistance of Trichophyton rubrum mediated by the ABC transporter TruMDR2	9
Fungi in sands of Mediterranean Sea beaches of Israel—Potential relevance to human health and well‐being	8
Cryptococcal infection in haematologic malignancies and haematopoietic stem cell transplantation	8
In vitro activities of antifungal drugs against a large collection of Trichophyton tonsurans isolated from wrestlers	8
Retinoid combined with photodynamic therapy against hyperkeratotic chromoblastomycosis: A case report and literature review	8
Candida spp bloodstream infections in a Latin American Pediatric Oncology Reference Center: Epidemiology and associated factors	8
The use of combined PCR, fluorescence in situ hybridisation and immunohistochemical staining to diagnose mucormycosis from formalin‐fixed paraffin‐embedded tissues	8
Activities of nine antifungal agents against Candida auris biofilms	8
Concurrent diagnosis of sinus fungus ball and invasive fungal sinusitis: A retrospective case series	8
Could cattle dung burning have contributed to the epidemic of COVID‐19‐associated mucormycosis in India? Results of an experimental aero‐mycological study	8
Treatment of pulmonary mucormycosis with adjunctive nebulized amphotericin B (MUCONAB trial): Results of an open‐label randomized controlled trial	8
Changing face of epidemiology of dermatophytoses in Chinese Mainland: A 30 years nationwide retrospective study from 1991 to 2020	8
European confederation of medical mycology expert consult—An ECMM excellence center initiative	8
Emergence of Candida auris in intensive care units in Algeria	8
Intravenous itraconazole compared with liposomal amphotericin B as empirical antifungal therapy in patients with neutropaenia and persistent fever	8
Isavuconazole nonwildtype Aspergillus fumigatus isolates from a global surveillance study display alterations in multiple genes involved in the ergosterol biosynthesis pathway not previously as	8
Diagnostic accuracy of Aspergillus‐specific antibodies for chronic pulmonary aspergillosis: A systematic review and meta‐analysis	8
Synergistic association of clioquinol with antifungal drugs against biofilm forms of clinical Fusarium isolates	8
Impact of biofilm production by Candida species and antifungal therapy on mortality of patients with candidemia	8
Antifungal drugs: An updated review of central nervous system pharmacokinetics	8